Search

everythinglearnresearchcommunity

for

Search:↓

Metformin helps manage polycystic ovary syndrome by improving insulin resistance and ovulation, but more research is needed on its full effects.

Testosterone therapy in transgender men has both desired effects like increased muscle mass and potential health risks such as higher cardiovascular risk.

Oral testosterone therapy raises heart risk more than other methods.

Testosterone supplements can increase muscle mass and strength in older men with low levels, but long-term effects and risks need more research.

Hidradenitis suppurativa is caused by genetic factors, inflammation, bacteria, hormones, and lifestyle factors like obesity and smoking.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

PCOS affects women's health by increasing the risk of diabetes, heart disease, and reproductive issues.

Balding men, especially young ones, may have higher risk of heart issues and diabetes; check cholesterol levels.

Adequate testosterone is crucial for men's health and quality of life, but its decline with age needs more research.

Athletes use steroids to enhance performance despite health risks and legal issues, and education on their dangers is needed.

Hair loss links to higher death risk from diabetes and heart disease; not a direct cause, but a marker for risk factors.

Short-term testosterone therapy in women seems safe with few mild side effects, but long-term effects need more research.

People with lichen planus have higher bad cholesterol and lower good cholesterol, increasing their risk for heart disease.

Stress from being transgender is linked to higher blood pressure at night and more inflammation, which may affect heart health.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

People with early onset baldness have higher bad cholesterol and lower good cholesterol, increasing their heart disease risk.

Hair loss linked to metabolic issues and insulin resistance; early assessment may reduce future health risks.

Small changes in hormones can significantly impact health, showing the importance of sensitive testing for chemicals that disrupt hormones.

People with lichen planus are more likely to have dyslipidemia, especially higher triglyceride levels.

Early onset baldness in men may indicate a condition similar to PCOS, linked to heart disease, diabetes, and prostate issues.

Acitretin is effective for severe psoriasis and can be used long-term due to no immunosuppression, but must be carefully monitored for side effects and is not for pregnant women.

People with alopecia areata have higher levels of a heart disease marker than those without hair loss.

Hormone therapy for prostate cancer can increase heart risks, especially in men with heart conditions.

The document concludes that more research is needed to fully understand the causes of PCOS.

Hormone therapy increases the risk of heart-related issues in transgender women and may affect heart health in transgender men.

Young men with early hair loss have slightly worse blood sugar and fat levels, suggesting possible health risks and need for monitoring.

People with hair loss have worse cholesterol levels, possibly linking hair loss to heart problems.

Taiwanese women with PCOS experience different symptoms based on age, with younger women facing more hormone imbalances and older women dealing with more metabolic issues.

Women with AGA have higher lipid levels, increasing heart disease risk.